Cellebrite DI’s (CLBT) “Buy” Rating Reiterated at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a research report released on Wednesday morning,Benzinga reports. They currently have a $28.00 target price on the stock. A number of other brokerages have also issued reports on CLBT. JPMorgan Chase & Co. raised their target price […]
Needham & Company LLC reaffirmed their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a research report released on Wednesday morning,Benzinga reports. They currently have a $28.00 target price on the stock. A number of other brokerages have also issued reports on CLBT. JPMorgan Chase & Co. raised their target price […]